New-Generation cancer pill enters human trials, aims for fewer side effects
Disease control
Recruiting now
This is the first study in people to test a new oral drug called SPR1020 for adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers hope this more targeted …
Phase: PHASE1, PHASE2 • Sponsor: Shanghai SciBrunch Therapeutics Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC